Podcast Episode Details
Back to Podcast Episodes
Lilly's Oral Weight-Loss Pill: A Game-Changer?
Eli Lillys oral weight-loss pill, orforglipron, shows promise in maintaining weight loss after switching from injectable GLP-one drugs. This development could revolutionize weight management, with Lilly potentially gaining a competitive edge in the market. In a late-stage trial, patients who took orforglipron after Wegovy or Zepbound showed better weight maintenance compared to a placebo. The FDA is considering an expedited review for Lillys pill, with a potential decision as early as March twenty-eighth.
The Daily News Now! - Every city. Every story. AI Powered.
Hosted on Acast. See acast.com/privacy for more information.
Published on 2 weeks ago